LATEST NEWS

May 24

Lift BioSciences Announces Abstract Publications at the American Society of Clinical Oncology (ASCO) Annual Meeting

London, 24 May 2024 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech company about to start clinical trials for...

May 16

LIfT BioSciences Awarded Innovate UK Grant to Accelerate Product Development of New IMAN Cell Therapy Variants

Groundbreaking in vivo studies will be progressed to explore the impact of IMAN cell therapies in solid tumour and immunology models...

Apr 10

LIfT demonstrates how IMANs rapidly infiltrate tumours and recruit in other immune cells to destroy solid tumours together

LIfT’s CEO Alex Blyth detailed how Immuno-Modulatory Alpha Neutrophils (IMANs) outperform traditional neutrophils by rapidly infiltrating...